VFA
Values First Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
90,974
+1,011
| +1% | +$5.12K | 0.25% | 111 |
|
|
2025
Q1 | $481K | Buy |
89,963
+188
| +0.2% | +$1.01K | 0.28% | 100 |
|
|
2024
Q4 | $607K | Buy |
89,775
+29,552
| +49% | +$200K | 0.33% | 82 |
|
|
2024
Q3 | $397K | Sell |
60,223
-1,540
| -2% | -$10.1K | 0.22% | 108 |
|
|
2024
Q2 | $463K | Sell |
61,763
-370
| -0.6% | -$2.78K | 0.28% | 90 |
|
|
2024
Q1 | $619K | Buy |
62,133
+2,928
| +5% | +$29.2K | 0.36% | 77 |
|
|
2023
Q4 | $584K | Buy |
59,205
+6,140
| +12% | +$60.5K | 0.35% | 87 |
|
|
2023
Q3 | $406K | Sell |
53,065
-361
| -0.7% | -$2.76K | 0.26% | 106 |
|
|
2023
Q2 | $399K | Buy |
53,426
+23,137
| +76% | +$173K | 0.24% | 109 |
|
|
2023
Q1 | $202K | Buy |
+30,289
| New | +$202K | 0.13% | 137 |
|